| Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study I Vaz-Luis, RA Ottesen, ME Hughes, R Mamet, HJ Burstein, SB Edge, ... Journal of Clinical Oncology 32 (20), 2142, 2014 | 258 | 2014 |
| Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis AR Ferreira, A Di Meglio, B Pistilli, AS Gbenou, M El-Mouhebb, S Dauchy, ... Annals of Oncology 30 (11), 1784-1795, 2019 | 157 | 2019 |
| Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National … I Vaz-Luis, RA Ottesen, ME Hughes, PK Marcom, B Moy, HS Rugo, ... Breast Cancer Research 14, 1-14, 2012 | 153 | 2012 |
| Patient prognostic score and associations with survival improvement offered by radiotherapy after breast-conserving surgery for ductal carcinoma in situ: a population-based … Y Sagara, RA Freedman, I Vaz-Luis, MA Mallory, SM Wong, F Aydogan, ... Journal of Clinical Oncology 34 (11), 1190, 2016 | 152 | 2016 |
| Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer MA Franzoi, E Agostinetto, M Perachino, L Del Mastro, E de Azambuja, ... The Lancet Oncology 22 (7), e303-e313, 2021 | 142 | 2021 |
| Long-term fatigue and cognitive disorders in breast cancer survivors F Joly, M Lange, M Dos Santos, I Vaz-Luis, A Di Meglio Cancers 11 (12), 1896, 2019 | 112 | 2019 |
| Managing side effects in adjuvant endocrine therapy for breast cancer R Condorelli, I Vaz-Luis Expert review of anticancer therapy 18 (11), 1101-1112, 2018 | 109 | 2018 |
| Effect of eribulin with or without pembrolizumab on progression-free survival for patients with hormone receptor–positive, ERBB2-negative metastatic breast cancer: A randomized … SM Tolaney, R Barroso-Sousa, T Keenan, T Li, L Trippa, I Vaz-Luis, ... JAMA oncology 6 (10), 1598-1605, 2020 | 103 | 2020 |
| Duration and toxicity of adjuvant trastuzumab in older patients with early-stage breast cancer: a population-based study I Vaz-Luis, NL Keating, NU Lin, H Lii, EP Winer, RA Freedman Journal of Clinical Oncology 32 (9), 927, 2014 | 97 | 2014 |
| Pregnancy after breast cancer: a systematic review and meta-analysis M Lambertini, E Blondeaux, M Bruzzone, M Perachino, RA Anderson, ... Journal of Clinical Oncology 39 (29), 3293-3305, 2021 | 94 | 2021 |
| Serum detection of nonadherence to adjuvant tamoxifen and breast cancer recurrence risk B Pistilli, A Paci, AR Ferreira, A Di Meglio, V Poinsignon, A Bardet, ... Journal of Clinical Oncology 38 (24), 2762, 2020 | 92 | 2020 |
| Impact of breast cancer treatment on employment: results of a multicenter prospective cohort study (CANTO) A Dumas, I Vaz Luis, T Bovagnet, M El Mouhebb, A Di Meglio, S Pinto, ... Journal of Clinical Oncology 38 (7), 734-743, 2020 | 91 | 2020 |
| Human epidermal growth factor receptor-2-positive breast cancer: does estrogen receptor status define two distinct subtypes? I Vaz-Luis, EP Winer, NU Lin Annals of Oncology 24 (2), 283-291, 2013 | 91 | 2013 |
| Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment S Terrisse, L Derosa, V Iebba, F Ghiringhelli, I Vaz-Luis, G Kroemer, ... Cell Death & Differentiation 28 (9), 2778-2796, 2021 | 87 | 2021 |
| UNICANCER: French prospective cohort study of treatment-related chronic toxicity in women with localised breast cancer (CANTO) I Vaz-Luis, P Cottu, C Mesleard, AL Martin, A Dumas, S Dauchy, O Tredan, ... ESMO open 4 (5), e000562, 2019 | 60 | 2019 |
| ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe I Vaz-Luis, M Masiero, G Cavaletti, A Cervantes, RT Chlebowski, ... Annals of oncology 33 (11), 1119-1133, 2022 | 58 | 2022 |
| Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study EG Kaboré, C Guenancia, I Vaz-Luis, A Di Meglio, B Pistilli, C Coutant, ... PLoS medicine 16 (12), e1002989, 2019 | 58 | 2019 |
| Breast cancer‐specific survival by age: Worse outcomes for the oldest patients RA Freedman, NL Keating, NU Lin, EP Winer, I Vaz‐Luis, J Lii, P Exman, ... Cancer 124 (10), 2184-2191, 2018 | 57 | 2018 |
| Patterns of chemotherapy, toxicity, and short-term outcomes for older women receiving adjuvant trastuzumab-based therapy RA Freedman, I Vaz-Luis, WT Barry, H Lii, NU Lin, EP Winer, NL Keating Breast cancer research and treatment 145, 491-501, 2014 | 50 | 2014 |
| Learning from social media: utilizing advanced data extraction techniques to understand barriers to breast cancer treatment RA Freedman, K Viswanath, I Vaz-Luis, NL Keating Breast cancer research and treatment 158, 395-405, 2016 | 49 | 2016 |
